Clinical trials: REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
- Condition REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
- Funder type Industry (pharma, biotech, devices)
- Has posted results yes
Inflammatory Diseases
Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants
The primary objective of this study is to evaluate the pharmacokinetics (PK) of efavaleukin alfa after single subcutaneous (SC) administration in healthy Chinese, Japanese, and Caucasian participants.
- Trial name
- NCT04987333
- Testing
- Efavaleukin alfa
- Where
- United Kingdom
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- Amgen